Evidence map›Paper›PMID 22199021›Full record

ReviewCold Spring Harbor perspectives in biology2012

Vesicular and plasma membrane transporters for neurotransmitters.

Randy D Blakely, Robert H Edwards

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 173 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. VMAT structures reveal exciting targets for drug development.Trends in pharmacological sciences · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Vesicular glutamate transporters are HNature communications · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Randy D BlakelyDepartment of Pharmacology and Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-8548, USA.
Robert H Edwards
University of California, San Francisco · USVanderbilt University · US

Funding

Regulation of Serotonin TransportersR01MH094527 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2011 to 2021
$4.4M
NIMH NIH HHS R01 MH094527
6 · The paper itself

Abstract

The regulated exocytosis that mediates chemical signaling at synapses requires mechanisms to coordinate the immediate response to stimulation with the recycling needed to sustain release. Two general classes of transporter contribute to release, one located on synaptic vesicles that loads them with transmitter, and a second at the plasma membrane that both terminates signaling and serves to recycle transmitter for subsequent rounds of release. Originally identified as the target of psychoactive drugs, these transport systems have important roles in transmitter release, but we are only beginning to understand their contribution to synaptic transmission, plasticity, behavior, and disease. Recent work has started to provide a structural basis for their activity, to characterize their trafficking and potential for regulation. The results indicate that far from the passive target of psychoactive drugs, neurotransmitter transporters undergo regulation that contributes to synaptic plasticity.

Indexed as

AnimalsCell MembraneExocytosisHumansNeurotransmitter AgentsNeurotransmitter Transport ProteinsSynaptic TransmissionSynaptic VesiclesNeurotransmitter AgentsNeurotransmitter Transport Proteins

Identifiers

PMID22199021
PMCPMC3281572
OpenAlexW2168202212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.